Anti-SEBP2/ SECISBP2/ SBP2 functional antibody

Anti-SEBP2/ SECISBP2/ SBP2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SECISBP2/SECISBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1640-Ab-1/ GM-Tg-hg-SE1640-Ab-2Anti-Human SECISBP2 monoclonal antibodyHuman
GM-Tg-rg-SE1640-Ab-1/ GM-Tg-rg-SE1640-Ab-2Anti-Rat SECISBP2 monoclonal antibodyRat
GM-Tg-mg-SE1640-Ab-1/ GM-Tg-mg-SE1640-Ab-2Anti-Mouse SECISBP2 monoclonal antibodyMouse
GM-Tg-cynog-SE1640-Ab-1/ GM-Tg-cynog-SE1640-Ab-2Anti-Cynomolgus/ Rhesus macaque SECISBP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1640-Ab-1/ GM-Tg-felg-SE1640-Ab-2Anti-Feline SECISBP2 monoclonal antibodyFeline
GM-Tg-cang-SE1640-Ab-1/ GM-Tg-cang-SE1640-Ab-2Anti-Canine SECISBP2 monoclonal antibodyCanine
GM-Tg-bovg-SE1640-Ab-1/ GM-Tg-bovg-SE1640-Ab-2Anti-Bovine SECISBP2 monoclonal antibodyBovine
GM-Tg-equg-SE1640-Ab-1/ GM-Tg-equg-SE1640-Ab-2Anti-Equine SECISBP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1640-Ab-1/ GM-Tg-hg-SE1640-Ab-2; GM-Tg-rg-SE1640-Ab-1/ GM-Tg-rg-SE1640-Ab-2;
GM-Tg-mg-SE1640-Ab-1/ GM-Tg-mg-SE1640-Ab-2; GM-Tg-cynog-SE1640-Ab-1/ GM-Tg-cynog-SE1640-Ab-2;
GM-Tg-felg-SE1640-Ab-1/ GM-Tg-felg-SE1640-Ab-2; GM-Tg-cang-SE1640-Ab-1/ GM-Tg-cang-SE1640-Ab-2;
GM-Tg-bovg-SE1640-Ab-1/ GM-Tg-bovg-SE1640-Ab-2; GM-Tg-equg-SE1640-Ab-1/ GM-Tg-equg-SE1640-Ab-2
Products NameAnti-SECISBP2 monoclonal antibody
Formatmab
Target NameSECISBP2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SECISBP2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1640-Ag-1Recombinant multi-species SEBP2/ SECISBP2/ SBP2 protein


    Target information

    Target IDGM-SE1640
    Target NameSECISBP2
    Gene ID79048,75420,79049,697442,476351,101096115,511202,100062130
    Gene Symbol and Synonyms2210413N07Rik,2810012K13Rik,SBP2,SECISBP2,THMA1
    Uniprot AccessionQ96T21,Q9QX72
    Uniprot Entry NameSEBP2_HUMAN,SEBP2_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187742
    Target ClassificationN/A

    The target: SECISBP2, gene name: SECISBP2, also named as SBP2. The protein encoded by this gene is one of the essential components of the machinery involved in co-translational insertion of selenocysteine (Sec) into selenoproteins. Sec is encoded by the UGA codon, which normally signals translation termination. The recoding of UGA as Sec codon requires a Sec insertion sequence (SECIS) element; present in the 3' untranslated regions of eukaryotic selenoprotein mRNAs. This protein specifically binds to the SECIS element, which is stimulated by a Sec-specific translation elongation factor. Mutations in this gene have been associated with reduction in enzymatic activity of type II iodothyronine deiodinase (a selenoprotein) and abnormal thyroid hormone metabolism. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.